ScienceDaily: Top Health News |
Researchers find immune component to rare neurodegenerative disease Posted: 21 Jul 2021 02:27 PM PDT Researchers have identified an immune protein tied to the rare neurodegenerative condition known as Niemann-Pick disease type C. The finding, made in mouse models, could offer a powerful new therapeutic target for Niemann-Pick disease type C, a condition that was identified more than a century ago but still lacks effective treatments. |
New study confirms relationship between toxic pollution, climate risks to human health Posted: 21 Jul 2021 02:27 PM PDT |
Ibrutinib effective treatment for difficult-to-treat forms of hairy cell leukemia, study finds Posted: 21 Jul 2021 11:19 AM PDT |
Study links vaccine immune response to age Posted: 21 Jul 2021 11:19 AM PDT |
Chromosomes separation under focus Posted: 21 Jul 2021 11:19 AM PDT During cell division, chromosomes are duplicated and separated so that one copy of each chromosome is inherited by each of the two emerging daughter cells. Correct distribution of chromosomes requires high accuracy and defects in this process can cause aberrant distribution of chromosomes and facilitate cancer development. By analyzing the structure of the protein responsible for chromosome separation, a team has shed light on the mechanisms controlling this essential player in cell division. |
Thumb-sized device quickly 'sniffs out' bad breath Posted: 21 Jul 2021 09:07 AM PDT |
Toward one drug to treat all coronaviruses Posted: 21 Jul 2021 09:07 AM PDT |
Breakthrough in detection of SARS-CoV-2 variant in wastewater Posted: 21 Jul 2021 09:07 AM PDT |
Wearable brain-machine interface turns intentions into actions Posted: 21 Jul 2021 09:06 AM PDT |
Toxicity testing on the placenta and embryo Posted: 21 Jul 2021 09:06 AM PDT |
Advancing the long-term well-being of people living with HIV Posted: 21 Jul 2021 09:06 AM PDT A global multidisciplinary group of HIV experts has developed a consensus statement identifying the key issues health systems must address in order to move beyond the longtime emphasis on viral suppression to instead deliver integrated, person-centered healthcare for people living with HIV throughout their lives. |
New method predicts COVID-19 severity, could help with hospital triage Posted: 21 Jul 2021 09:06 AM PDT |
Breastfeeding, even for a few days, linked to lower blood pressure in early childhood Posted: 21 Jul 2021 07:24 AM PDT |
Cognitive decline may help predict future fracture risk in women Posted: 21 Jul 2021 07:24 AM PDT |
Residential proximity to oil and gas drilling linked to lower birthweights in newborns Posted: 21 Jul 2021 07:23 AM PDT |
C is for Vitamin C -- a key ingredient for immune cell function Posted: 21 Jul 2021 07:23 AM PDT |
Blocking how the malaria parasite suppresses the immune response Posted: 21 Jul 2021 07:23 AM PDT |
Smartphone gaming can be harmful for some seeking relief from boredom, study finds Posted: 21 Jul 2021 07:23 AM PDT |
Novel method predicts if COVID-19 clinical trials will fail or succeed Posted: 21 Jul 2021 07:23 AM PDT |
Scientists link frailty and neurocognitive decline in childhood cancer survivors Posted: 21 Jul 2021 07:23 AM PDT |
Nanoparticles create heat from light to manipulate electrical activity in neurons Posted: 21 Jul 2021 07:23 AM PDT |
Effectiveness of mRNA vaccines against the Alpha and Beta variants in France Posted: 21 Jul 2021 07:22 AM PDT |
Cancer: Information theory to fight resistance to treatments Posted: 21 Jul 2021 07:22 AM PDT A major challenge in cancer therapy is the adaptive response of cancer cells to targeted therapies. Although this adaptive response is theoretically reversible, such a reversal is hampered by numerous molecular mechanisms that allow the cancer cells to adapt to the treatment. A team has used information theory, in order to objectify in vivo the molecular regulations at play in the mechanisms of the adaptive response and their modulation by a therapeutic combination. |
Many ICU staff have experienced mental health conditions in COVID-19 pandemic Posted: 21 Jul 2021 07:22 AM PDT |
SARS-CoV-2 variant B.1.617 gives the immune system a hard time Posted: 21 Jul 2021 07:22 AM PDT Researchers have investigated the SARS-CoV-2 variant B.1.617 in detail. In cell culture studies, they found that this variant can infect certain lung and intestinal cell lines more efficiently than the original virus. The researchers also demonstrated that B.1.617 is less sensitive to inhibition by antibodies present in the blood of convalescent or vaccinated individuals and resistant to a therapeutic antibody used for COVID-19 treatment. |
Long-term prognosis for some patients with severe brain injury better than expected, study finds Posted: 20 Jul 2021 10:52 AM PDT |
You are subscribed to email updates from Top Health News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |